Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy
US10736974B2 · kind B2 · utility
4Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2015 |
| Grant date | Aug 11, 2020 |
| Priority date | — |
| Expiry date | Oct 22, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K49/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Carbamate and beta-amino acid urea-based scaffolds that have high binding affinity to PSMA are disclosed. These scaffolds can be radiolabeled and used for imaging cells and tumors that express PSMA or for cancer radiotherapy. These compounds also can comprise a fluorescent dye and be used for imaging cells and tumors that express PSMA or for photodynamic therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.